grant

Centre of Research Excellence in Pulmonary and Environmental Medicine. [ 2007 - 2013 ]

Also known as: A Centre studying inhalational lung diseases, trains young researchers and develops new tests and treatments.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/458543]

Researchers: Prof Bruce Robinson (Principal investigator) ,  A/Pr Steven Mutsaers Prof Anna Nowak Prof Arthur Musk Prof Philip Thompson
View all 6 related researchers

Brief description This Centre will study inhalational lung diseases, ie diseases caused by substances such as asbestos, cigarette smoke, air pollutants and allergens. Australia has of the highest incidences in the world of at least 2 of the diseases to be studied, asbestos- and allergen-induced lung diseases. These two alone are estimated to cost the Australian economy over $100 million -yr and $1 billion respectively in direct health costs plus loss of productivity and compensation. Furthermore COPD on of our other major areas of interest is the 4th leading cause of death in males and conservatively costs the economy over one billion dollars per year as well as being the leading cause of disability in the elderly. It is predicted that COPD will be the 4th most common disease worldwide by 2020. As such this area of study is important for Australia and internationally and any advances will deliver major economic and health benefits. We will study the role of blood and sputum tests in the diagnosis, monitoring, screening and management of lung diseases caused by asbestos, cigarette smoke, air pollutants and allergens ie. mesothelioma, asthma, COPD and lung cancer. We will apply modern DNA 'gene chip' methods to study the pathogenesis of these diseases and help us to identify new treatment targets. This will also be used to guide genetic searches for polymorphism's, spliced variants and DNA modification(epigentics) in COPD and lung cancer. Genetic studies of sensitivity to air pollution will be used to define at risk patients We will also evaluate how the method of cell death that occurs during some therapies eg. in cancer and allergy-asthma, might alter how the body responds and thus help us develop novel therapeutic strategies for these diseases. This research program should lead to new tests and treatments and at the same time promote the training of a new generation of young researchers in this field and so ensure that the work continues long term

Funding Amount $AUD 2,007,200.00

Funding Scheme Centres of Research Excellence

Notes Centre of Clinical Research Excellence

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]